Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

VIRTUS DIVERSIFIED INCOME & CONVERTIBLE FUND (ACV)

  • Business News
  • April 28, 2026, 20:20 UTC
  • 0
  • 1 comments

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Market reaction Comment Full text

O-I GLASS, INC. /DE/ (OI)

  • Business News
  • April 28, 2026, 20:20 UTC
  • 0
  • 1 comments

O-I Glass Reports First Quarter 2026 Results

Market reaction Comment Full text

EQUITY LIFESTYLE PROPERTIES INC (ELS)

  • Business News
  • April 28, 2026, 20:19 UTC
  • 0
  • 1 comments

ELS Declares Second Quarter 2026 Dividend

Market reaction Comment Full text

TWO HARBORS INVESTMENT CORP. (TWO)

  • Business News
  • April 28, 2026, 20:17 UTC
  • 0
  • 1 comments

TWO and CrossCountry Mortgage, LLC Announce Amended Merger Agreement

Market reaction Comment Full text

ARTISAN PARTNERS ASSET MANAGEMENT INC. (APAM)

  • Business News
  • April 28, 2026, 20:16 UTC
  • 0
  • 1 comments

Artisan Partners Asset Management Inc. Reports 1Q26 Results and Quarterly Dividend

Market reaction Comment Full text

VOYA FINANCIAL, INC. (VOYA)

  • Business News
  • April 28, 2026, 20:16 UTC
  • 0
  • 1 comments

Voya Financial declares common and preferred stock dividends

Market reaction Comment Full text

Spectral AI (MDAIW)

  • Business News
  • April 28, 2026, 20:15 UTC
  • 0
  • 1 comments

Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call

Market reaction Comment Full text

Agilent Technologies Inc. (A)

  • Business News
  • April 28, 2026, 20:15 UTC
  • 0
  • 1 comments

Agilent Technologies, Inc. - Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Market reaction Comment Full text

Becton Dickinson and Company (BDX)

  • Business News
  • April 28, 2026, 20:15 UTC
  • 0
  • 1 comments

BD Board Declares Dividend

Market reaction Comment Full text

RENAISSANCERE HOLDINGS LTD (RNR)

  • Business News
  • April 28, 2026, 20:15 UTC
  • 0
  • 1 comments

RenaissanceRe Reports $284.5 Million of Quarterly Net Income Available to Common Shareholders and $590.5 Million of Operating Income Available to Common Shareholders in Q1 2026.

Market reaction Comment Full text
  • Previous
  • 57
  • 58
  • 59
  • 60
  • 61
  • Next

Search

News categories

  • Technical Exchange News(12129)
  • Event(5663)
  • SEC News(254922)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152000)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin